多种肝功能评分系统预测血浆置换治疗肝衰竭患者预后的价值探讨

doi:10.3969/j.issn.1672-5069.2014.06.025

Abstract

Cao Li, Xu Haifeng. Model for end-stage liver disease and Child-Pugh score in short-term prediction of patients with liver failure receiving plasma exchange[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 652-655.

References

[1] Child III CG,Turcotte JG. Surgery and portal hypertension. In: Child III CG（Ed）. The liver and portal hypertension. Philadelphia:Saunder,1964:50.
[2] Pugh RN,Murray-Lyon IM,Dawson JL,et al. Transection of the oesophagus for bleeding oesophageal variees. Br J Surg,1973,60（8）:646-649.
[3] Malinchoc M,Kamath PS,Gorlon FD,et a1.A model to predict poor survival in patients undergoing trunsjugular intrahepatic portosystemic shunts.Hepatology,2000,3l：864-871.
[4] Bigging SW,Kim WR,Terrault,NA,et al. Evidence-based incorporation of serum sodium concentration into MELD.Gastroenterology,2006,130（6）:1652-1660.
[5] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南.实用肝脏病杂志,2013,16（3）：210-216.
[6] Kamath P S,Wiesner R H,Malinchoc M,et a1. A model to predictsurvival in patients with end -stage liver disease.Hepatology,2001,33（2）：464-470.
[7] Ruf AE,Kremers WK,Chavez LL,et al. Addition of serum sodiuminto the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl,2005,11（3）：336-343.
[8] 叶任高, 陆再英. 内科学. 北京: 人民卫生出版社, 2004:448.
[9] 丁红玲. 终末期肝病模型评分对重型肝炎患者的预测价值. 中国误诊学杂志,2012,12（4）：828.
[10] 徐琴,张跃新,孙丽华. MELD在评价慢性重型肝炎预后中的应用. 新疆医学,2009:39（4）:1-3.
[11] 高艳颖,韩涛,阚志超. MELD-Na、MELD及Child-Pugh评分系统预测人工肝治疗的肝衰竭预后价值的探讨.天津医药,2009:37（7）：547-549.
[12] Kim JM,Kwon CH,Joh JW,et al. Can themodel for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A. Ann Surg Treat Res,2014,86（3）:122-129.
[13] Duan BW,Lu SC,Wang ML,et al. Liver transplantation inacute-on-chronic liver failurepatients with high model for end-stage liver disease （MELD） scores:a single center experience of 100 consecutive cases. J Surg Res,2013,183（2）:936-943.
[14] Basile-Filho A,Nicolini EA,Auxiliadora-Martins M,et al.Comparison of acutephysiology and chronic health evaluation II death risk,Child-Pugh,Charlson,and model for end-stage liver disease indexes to predict early mortality after liver transplantation. Transplant Proc,2011,43（5）:1660-1664.
[15] Westbrook RH,Yeoman AD,O'Grady JG,et al. Modelfor end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol,2011,9（8）:694-699.
[16] Guo Z,He X,Wu L,et al. Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today,2010,40（1）:38-45.
[17] Benedeto-Stojanov D,Nagorni A,Bjelakovi G,et al. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding. Vojnosanit Pregl,2009,66（9）:724-728.
[18] Boursier J,Cesbron E,Tropet AL,et al. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality incirrhotic patients. J Clin Gastroenterol,2009,43（6）:580-585.
[19] Flores-Rendón AR,González-González JA, García-Compean D,et al. Model for end stage of liver disease （MELD） is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding. Ann Hepatol,2008,7（3）:230-234.
[20] Suman A,Barnes DS,Zein NN,et al. Predicting outcome after cardiac surgery in patients with cirrhosis:a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol,2004,2（8）:719-723.
[21] Boin IF,Leonardi MI,Pinto AO,et al. Liver transplant recipients mortality on the waiting list:long-termcomparison to Child-Pugh classification and MELD. Transplant Proc,2004,36（4）:920-922.

Model for end-stage liver disease and Child-Pugh score in short-term prediction of patients with liver failure receiving plasma exchange

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Wang Yuan, Dang Panyu, Wang Wei. Application of plasma exchange and continuous plasma dialysis filtration in the treatment of patients with acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 541-544.
[2]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[3]	Zhang Xiuling, Duan Zhiwen, Yang Ruidong, Zhang Xiaomin, Yang Li, Yang Haiqiu, Li Wu. Plasma exchange combined with double plasma molecular adsorption system in treatment of patients with liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 289-290.
[4]	Zhang Jing, Yin Fang, Luo Guanhong, et al.. Effect of plasma exchange and sequential double plasma molecular adsorbent therapy on short survival in patients with hepatitis B virus-induced acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 85-88.
[5]	Yang Xiaoling, Zhou Qiang, Zheng Chunhua, et al. Analysis of plasma exchange and continuous blood purification in treatment of patients with hepatitis B liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 469-470.
[6]	Chen Qian, Jiao Fangzhou, Zhang Haiyue. Protective effect of histone deacetylase inhibitor ACY1215 on hepatocyte mitochondria in rats with acute hepatic failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 672-675.
[7]	Li Ming, Xin Kefeng, Wu Zhaojin, et al.. Clinical efficacy of plasma exchange in treatment of patients with hepatitis E and hyperbilirubinemia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 408-411.
[8]	Wang Chaoxu, Li Yening, Wang Wenlong, et al.. Efficacy and cytokine changes in patients with acute-on-chronicliver failure receiving plasma exchange and bilirubin adsorption [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 492-493.
[9]	Zhang Xin.. Efficacy and safety of glucocorticoids in treatment of patients with hepatic failure:A Meta-analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 73-77.
[10]	Zhu Qirong, Wang Chuanlin, Liu Jiao, et al.. Changes of serum cytokines in patients with hepatic failure after molecular adsorption recycling system therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 107-108.
[11]	Guo Wei,Li Weina,Ning Qin. Definition and natural history of severe hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 264-265.
[12]	Chen Yongping,Xu Lanman. Diagnosis and management of patients with hepatic failure: What's going on？ [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 266-269.
[13]	Fan Jinghua, Chen Hongying, Wang Hongtu. Plasma exchange combined with plasma perfusion in treatment of patients with liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 184-186.
[14]	Liu Feifei, Wu Jiyuan, Zhang Haiyue. Clinical characteristics of patients with hepatitis B-induced acute-on-chronic liver failure and the effects of plasma exchanges on their prognosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 188-191.
[15]	Fang Mingxia, Qi Lei. Clinical observation of plasma exchange in the treatment of patients with chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 292-293.